BXRX

Baudax Bio, Inc. Common Stock
BXRX

Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

53 hedge funds and large institutions have $34.8M invested in Baudax Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.68M
2
+$3.56M
3
+$3.06M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.62M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$188K
27
$184K
28
$173K
29
$133K
30
$129K
31
$121K
32
$120K
33
$112K
34
$92K
35
$84K
36
$79K
37
$70K
38
$68K
39
$59K
40
$58K
41
$42K
42
$34K
43
$32K
44
$31K
45
$22K
46
$19K
47
$18K
48
$15K
49
$13K
50
$11K
1
2
3